Estrogen Receptor Modulators: Clinical Trials

2 trials of Estrogen Receptor Modulators, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Estrogen Receptor Modulators: new trials by email Literature Review of Estrogen Receptor Modulators trials Research Report on Estrogen Receptor Modulators

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Atamestane, Toremifene, Letrozole - Breast Neoplasms, Neoplasms, Hormone-Dependent
Phase 3TerminatedIntarcia Therapeutics8422004-12-012007-08-23
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
atamestane, toremifene, letrozole - Breast Neoplasms, Neoplasms, Hormone-dependent
Phase 3CompletedIntarcia Therapeutics8652002-06-012015-07-31

Conditions studied

Breast Neoplasms (2)  ·  Carcinoma, Ductal, Breast (2)  ·  Carcinoma, Lobular (2)  ·  Neoplasms, Hormone-Dependent (2)

Sponsors

Intarcia Therapeutics (2)

Countries

Russia (2)  ·  Ukraine (2)  ·  United States (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  Romania (1)

Top investigators

Edith Perez, MD (1)  ·  Paul Goss, M.D. (1)